0
InflaRx N.V. Banner Image

InflaRx N.V. has reached its limit for free report views

Work for InflaRx N.V.? Upgrade Your Profile and unlock all your annual reports.

InflaRx N.V.

  • Ticker IFRX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
InflaRx N.V. Logo Image
  • 11-50 Employees
  • Based in Jena, Germany
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. Complement C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. InflaRx was founded in 2007, and the groupMore has offices and subsidiaries in Jena and Munich, Germany, as well as Ann Arbor, MI, USA.
InflaRx N.V.

Most Recent Annual Report

InflaRx N.V. MOST RECENT 2019 Annual Report

Report Locked. InflaRx N.V. has reached its limit for free report views.

Older/Archived Annual Reports